American Vanguard Corporation (AVD) - Total Liabilities
Based on the latest financial reports, American Vanguard Corporation (AVD) has total liabilities worth $475.62 Million USD as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore net asset growth rate of American Vanguard Corporation to track the company's year-over-year net asset growth rate.
American Vanguard Corporation - Total Liabilities Trend (1986–2025)
This chart illustrates how American Vanguard Corporation's total liabilities have evolved over time, based on quarterly financial data. See American Vanguard Corporation free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.
American Vanguard Corporation Competitors by Total Liabilities
The table below lists competitors of American Vanguard Corporation ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Eyenovia Inc
NASDAQ:EYEN
|
USA | $15.70 Million |
|
Welspun Investments and Commercials Limited
NSE:WELINV
|
India | Rs909.56 Million |
|
Pender Growth Fund VCC Inc
V:PTF
|
Canada | CA$427.55K |
|
Sab Zenzele Kabili Holdings
JSE:SZK
|
South Africa | ZAC3.48 Billion |
|
Power Metals Corp
V:PWM
|
Canada | CA$1.94 Million |
|
Sheetal Cool Products Limited
NSE:SCPL
|
India | Rs1.08 Billion |
|
Emami Paper Mills Limited
NSE:EMAMIPAP
|
India | Rs12.83 Billion |
|
BARK, Inc.
NYSE:BARK
|
USA | $107.42 Million |
Liability Composition Analysis (1986–2025)
This chart breaks down American Vanguard Corporation's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see American Vanguard Corporation (AVD) total market value.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.32 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 2.51 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.71 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how American Vanguard Corporation's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for American Vanguard Corporation (1986–2025)
The table below shows the annual total liabilities of American Vanguard Corporation from 1986 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | $404.14 Million | +0.13% |
| 2024-12-31 | $403.61 Million | +1.53% |
| 2023-12-31 | $397.54 Million | +11.56% |
| 2022-12-31 | $356.33 Million | +10.86% |
| 2021-12-31 | $321.42 Million | +0.58% |
| 2020-12-31 | $319.56 Million | -7.89% |
| 2019-12-31 | $346.93 Million | +31.24% |
| 2018-12-31 | $264.36 Million | +14.80% |
| 2017-12-31 | $230.28 Million | +56.02% |
| 2016-12-31 | $147.60 Million | -15.76% |
| 2015-12-31 | $175.21 Million | -17.42% |
| 2014-12-31 | $212.17 Million | +11.87% |
| 2013-12-31 | $189.65 Million | +8.71% |
| 2012-12-31 | $174.45 Million | +14.72% |
| 2011-12-31 | $152.07 Million | +31.82% |
| 2010-12-31 | $115.36 Million | +13.52% |
| 2009-12-31 | $101.62 Million | -22.42% |
| 2008-12-31 | $130.99 Million | +20.35% |
| 2007-12-31 | $108.84 Million | -23.08% |
| 2006-12-31 | $141.50 Million | +40.41% |
| 2005-12-31 | $100.78 Million | +72.64% |
| 2004-12-31 | $58.37 Million | +3.50% |
| 2003-12-31 | $56.40 Million | +60.20% |
| 2002-12-31 | $35.20 Million | +1.73% |
| 2001-12-31 | $34.61 Million | -5.97% |
| 2000-12-31 | $36.80 Million | +24.72% |
| 1999-12-31 | $29.51 Million | -17.34% |
| 1998-12-31 | $35.70 Million | +5.31% |
| 1997-12-31 | $33.90 Million | +18.53% |
| 1996-12-31 | $28.60 Million | +34.27% |
| 1995-12-31 | $21.30 Million | -17.44% |
| 1994-12-31 | $25.80 Million | +14.67% |
| 1993-12-31 | $22.50 Million | +4.17% |
| 1992-12-31 | $21.60 Million | -3.57% |
| 1991-12-31 | $22.40 Million | +10.34% |
| 1990-12-31 | $20.30 Million | +86.24% |
| 1989-12-31 | $10.90 Million | +39.74% |
| 1988-12-31 | $7.80 Million | +11.43% |
| 1987-12-31 | $7.00 Million | +22.81% |
| 1986-12-31 | $5.70 Million | -- |
About American Vanguard Corporation
American Vanguard Corporation, through its subsidiaries, develops, manufactures, and markets synthetic, biological, and biorational products for agricultural, commercial, and consumer uses in the United States and internationally. The company synthesizes and formulates chemicals and ferments and extracts microbial products for crops, turf, ornamental plants, and human and animal health protection… Read more